top
Search terms
Results 1 - 6 of 6 - ordered by :
Escardio

Prof. Zannad points out that, “Rivaroxaban is approved at higher doses to treat conditions such as atrial fibrillation (AF) and venous thromboembolism, but in COMMANDER HF, patients were ...

Date : 28/08/2018
Escardio

Dr. Kelley Branch Among patients with stable coronary artery disease (CAD) and/or peripheral artery disease (PAD), those with heart failure are at a higher risk of major adverse cardiovascular events ...

Date : 29/05/2018
Escardio

Formerly considered diuretics, mineralocorticoid receptor antagonists (MRAs) “are still underused in routine clinical practice, but our data may hopefully contribute to expanded use of these ...

Date : 28/08/2017
Escardio

Beta blockers, aldosterone antagonists and in particular ACE-inhibitors have been the gold standard for the treatment of patients suffering from heart failure due to reduced ejection fraction for the ...

Date : 28/01/2015
Escardio

Frailty increases risk of death or repeat heart attack in elderly MI patients by three-fold Frailty increases the risk of death or repeat heart attack in elderly MI patients by three-fold, according ...

Date : 30/08/2014
Escardio

The primary outcome measure was time to first event for the composite endpoint of cardiovascular death, resuscitated death, myocardial infarction, stroke, unplanned hospitalisation for heart failure, ...

Date : 26/08/2012